Crcam Ille Et Vilaine (XPAR:CIV) 1-Year Sharpe Ratio: 0.62 (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:CIV Crcam Ille Et Vilaine XPAR:CIV
55 GF Score
Price €118.06
GF Value €62.72
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Crcam Ille Et Vilaine 1-Year Sharpe Ratio?

Crcam Ille Et Vilaine XPAR:CIV +0.05% 55 1-Year Sharpe Ratio is 0.62 as of Aug. 29, 2026. GuruFocus rates XPAR:CIV with a GF Score™ of 55/100 and a GF Value™ of €62.72 (Significantly Overvalued). The stock has 2 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-29), Crcam Ille Et Vilaine's 1-Year Sharpe Ratio is 0.62.


Crcam Ille Et Vilaine  (XPAR:CIV) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Crcam Ille Et Vilaine 1-Year Sharpe Ratio Related Terms


Crcam Ille Et Vilaine 1-Year Sharpe Ratio Competitor Comparison

For the Banks - Regional subindustry, Crcam Ille Et Vilaine's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Crcam Ille Et Vilaine 1-Year Sharpe Ratio vs Banks Industry

For the Banks industry and Financial Services sector, Crcam Ille Et Vilaine's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Crcam Ille Et Vilaine's 1-Year Sharpe Ratio falls into.


XPAR:CIV
55GF Score
Crcam Ille Et Vilaine XPAR:CIV
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crcam Ille Et Vilaine 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.62 mean?
Crcam Ille Et Vilaine (XPAR:CIV) has a 1-Year Sharpe Ratio of 0.62 as of Aug. 29, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Crcam Ille Et Vilaine and its competitors.
Is Crcam Ille Et Vilaine's 1-Year Sharpe Ratio too high?
Crcam Ille Et Vilaine's current 1-Year Sharpe Ratio is 0.62. Overall, Crcam Ille Et Vilaine has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crcam Ille Et Vilaine's 1-Year Sharpe Ratio compare to competitors?
Crcam Ille Et Vilaine's 1-Year Sharpe Ratio of 0.62 can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Banks company?
A good 1-Year Sharpe Ratio depends on the Banks industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Crcam Ille Et Vilaine and its competitors. Crcam Ille Et Vilaine's current 1-Year Sharpe Ratio is 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crcam Ille Et Vilaine stock overvalued right now?
Based on GuruFocus' analysis, Crcam Ille Et Vilaine (XPAR:CIV) is currently considered Significantly Overvalued. The stock's GF Value™ is €62.72, compared to a current price of €118.06 — trading 88.2% above its estimated fair value. The current 1-Year Sharpe Ratio is 0.62. Crcam Ille Et Vilaine's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Crcam Ille Et Vilaine (XPAR:CIV), the current 1-Year Sharpe Ratio is 0.62 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crcam Ille Et Vilaine (XPAR:CIV) Overvalued in 2026?

Based on GuruFocus' analysis, Crcam Ille Et Vilaine stock appears to be overvalued. The current stock price of €118.06 is trading 88.2% above its estimated GF Value™ of €62.72. GuruFocus considers Crcam Ille Et Vilaine to be Significantly Overvalued.

Key valuation signals for XPAR:CIV:

  • 1-Year Sharpe Ratio: 0.62
  • GF Value™: €62.72 vs. price of €118.06 (88.2% above fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the XPAR:CIV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Crcam Ille Et Vilaine Business Description

Other Exchanges 0IN0:UK
Address 45 boulevard de la Liberte CS 64017, Rennes, FRA, 35000
Crcam Ille Et Vilaine Formerly Crédit Agricole d'Ille-et-Vilaine is involved in providing banking services in France. The company offers savings, mortgages, loans, and account management services, as well as insurance products. It serves individuals, professionals, farmers, companies, and associations.
55GF Score

Get the complete analysis for XPAR:CIV

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€118.06
Price
€62.72
GF Value